What drove 4597.T stock’s heavy trading on 15 Jan 2026?

High turnover occurred as traders repositioned ahead of clinical and earnings catalysts. Volume hit **33,559,200** shares, suggesting retail and program activity with price finishing at **JPY 29.00** on JPX.

What is Meyka AI’s forecast for 4597.T stock?

Meyka AI's forecast model projects a yearly price of **JPY 23.50**, implying **-18.97%** from the current **JPY 29.00**. Forecasts are model-based projections and not guarantees.

How do Solasia’s fundamentals compare to Healthcare peers?

Solasia shows negative EPS **-8.96** and high price-to-sales **22.75**, while Healthcare peers average PE around **24.03** and higher earnings stability, making Solasia an outlier with greater risk.

When is the next earnings or catalyst for 4597.T?

Solasia lists an earnings announcement on **13 Feb 2026**. Clinical milestones for SP-05 and SP-02 are additional high-impact catalysts to monitor before and after that date.

JP Stocks

Solasia Pharma (4597.T JPX) closed JPY 29.00 on 15 Jan 2026: active trade signals to watch

ByDanny Kontos January 15, 2026January 15, 2026

Solasia Pharma K.K. (4597.T) was one of the JPX’s most active names on 15 Jan 2026, closing at JPY 29.00 on volume of 33,559,200 shares as the market closed. The 4597.T stock shows a tight intraday range, with a day low of JPY 28.00 and day high of JPY 29.00, and trading remains well above the year low of JPY 27.00. Volume relative to the 50-day and 200-day averages suggests heightened retail and program interest. We summarise the drivers behind today’s liquidity, the fundamentals that matter, and what active traders should watch next